• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Galectin Therapeutics, Inc. (GALT)

    -NCM
    3.69 0.00(0.00%) 3:59PM EST
    - Nasdaq Real Time Price
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (12,088) (9,675) (10,915)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation12  9  9  
    Adjustments To Net Income3,789  2,792  3,769  
    Changes In Accounts Receivables -   -  234  
    Changes In Liabilities842  (571)1,261  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(39)(55)(34)
    Total Cash Flow From Operating Activities (7,484) (7,500) (5,676)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures -  (5)(5)
    Investments -   -   -  
    Other Cash flows from Investing Activities -  69  (10)
    Total Cash Flows From Investing Activities -   64   (15)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock8,609  10,403  6,197  
    Net Borrowings -   -   -  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 8,609   10,403   6,197  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 1,125   2,967   506  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.